Susquehanna International Group
RVMD icon

Susquehanna International Group’s Revolution Medicines RVMD Stock Holding History

Susquehanna International Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5M Sell
51,385
-131,836
-72% -$13.3M ﹤0.01% 4223
2025
Q4 		$14.6M Buy
183,221
+65,013
+55% +$4.26M ﹤0.01% 2573
2025
Q3 		$5.52M Sell
118,208
-67,461
-36% -$2.64M ﹤0.01% 3919
2025
Q2 		$6.83M Sell
185,669
-58,384
-24% -$2.24M ﹤0.01% 3424
2025
Q1 		$8.63M Buy
244,053
+97,865
+67% +$3.97M ﹤0.01% 2729
2024
Q4 		$6.39M Buy
146,188
+91,518
+167% +$4.62M ﹤0.01% 3235
2024
Q3 		$2.48M Buy
54,670
+16,906
+45% +$736K ﹤0.01% 4866
2024
Q2 		$1.47M Sell
37,764
-34,873
-48% -$1.3M ﹤0.01% 5729
2024
Q1 		$2.34M Sell
72,637
-76,015
-51% -$2.25M ﹤0.01% 4988
2023
Q4 		$4.26M Sell
148,652
-93,820
-39% -$2.25M ﹤0.01% 3983
2023
Q3 		$6.71M Buy
242,472
+52,552
+28% +$1.56M ﹤0.01% 3087
2023
Q2 		$5.08M Sell
189,920
-116,903
-38% -$2.87M ﹤0.01% 3508
2023
Q1 		$6.65M Buy
306,823
+250,484
+445% +$6.17M ﹤0.01% 3028
2022
Q4 		$1.34M Sell
56,339
-58,259
-51% -$1.24M ﹤0.01% 5530
2022
Q3 		$2.26M Buy
114,598
+94,959
+484% +$2.09M ﹤0.01% 4669
2022
Q2 		$383K Sell
19,639
-35,382
-64% -$689K ﹤0.01% 8905
2022
Q1 		$1.4M Sell
55,021
-21,335
-28% -$464K ﹤0.01% 6308
2021
Q4 		$1.92M Buy
76,356
+3,910
+5% +$110K ﹤0.01% 5604
2021
Q3 		$1.99M Buy
72,446
+34,379
+90% +$1M ﹤0.01% 5840
2021
Q2 		$1.21M Sell
38,067
-147,884
-80% -$5.16M ﹤0.01% 7232
2021
Q1 		$8.53M Buy
185,951
+171,148
+1,156% +$7.67M ﹤0.01% 3025
2020
Q4 		$586K Buy
14,803
+6,361
+75% +$252K ﹤0.01% 7940
2020
Q3 		$294K Buy
+8,442
New +$234K ﹤0.01% 8748
2020
Q2 		– Sell
-27,394
Closed -$600K – 10799
2020
Q1 		$600K Buy
+27,394
New +$758K ﹤0.01% 6529

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Susquehanna International Group's RVMD Position: Q1 2026 in Review

Susquehanna International Group reduced its Revolution Medicines (RVMD) stake by 72% in Q1 2026, selling an estimated $13.3M and leaving 51,385 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #4223.

Susquehanna International Group first reported a position in RVMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $14.6M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Susquehanna International Group held 51,385 shares of Revolution Medicines worth $5M as of Q1 2026.
  • Susquehanna International Group sold 131,836 Revolution Medicines shares in Q1 2026, an estimated $13.3M.
  • Revolution Medicines made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4223 holding.
  • Susquehanna International Group first reported a position in Revolution Medicines in Q1 2020 and has held it in 24 quarters since.
  • Susquehanna International Group's Revolution Medicines position peaked at $14.6M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.